Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5176709
Max Phase: Preclinical
Molecular Formula: C44H56FN7O13S
Molecular Weight: 942.03
Associated Items:
ID: ALA5176709
Max Phase: Preclinical
Molecular Formula: C44H56FN7O13S
Molecular Weight: 942.03
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)c1ccc(S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc1)C(=O)N[C@@H](C)C(=O)N[C@H]1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)C1
Standard InChI: InChI=1S/C44H56FN7O13S/c1-20(2)13-30(50-34(54)16-46-39(59)21(3)47-41(61)23-5-9-26(10-6-23)66-44-38(58)37(57)36(56)33(19-53)65-44)42(62)48-22(4)40(60)49-24-11-12-51(17-24)32-15-31-27(14-29(32)45)35(55)28(43(63)64)18-52(31)25-7-8-25/h5-6,9-10,14-15,18,20-22,24-25,30,33,36-38,44,53,56-58H,7-8,11-13,16-17,19H2,1-4H3,(H,46,59)(H,47,61)(H,48,62)(H,49,60)(H,50,54)(H,63,64)/t21-,22-,24-,30-,33+,36-,37-,38+,44-/m0/s1
Standard InChI Key: GTJRJBNDSPWJJC-FJCGINHCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 942.03 | Molecular Weight (Monoisotopic): 941.3641 | AlogP: -0.27 | #Rotatable Bonds: 18 |
Polar Surface Area: 298.19 | Molecular Species: ACID | HBA: 15 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 5.87 | CX Basic pKa: | CX LogP: -0.72 | CX LogD: -2.26 |
Aromatic Rings: 3 | Heavy Atoms: 66 | QED Weighted: 0.08 | Np Likeness Score: -0.49 |
1. Meiers J, Rox K, Titz A.. (2022) Lectin-Targeted Prodrugs Activated by Pseudomonas aeruginosa for Self-Destructive Antibiotic Release., 65 (20.0): [PMID:36201248] [10.1021/acs.jmedchem.2c01214] |
Source(1):